Kilitch Drugs (India) Limited

KILITCH.NS·NSE·Healthcare
Compare
202.24+0.13 (+0.06%)today
At close: Oct 23, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close202.11
Open203.99
Day range196.10211.61
52-week range117.25267.90
Off day high−4.43%
Off 52-week high−24.51%
Volume144.15K
Avg. volume (3M)53.54K
Market cap7.07B
EPS (TTM)8.80
Forward P/E13.22
P/E ratio (TTM)22.98
Dividend yield—
Beta (5Y)0.31
Shares outstanding34.96M
Short interest—
Earnings dateAug 6, 2025 (est.)
Analyst target—
Profit margin12.67%

Against its peers

Compare in full ›
KILITCH.NS IOLCP.BO THEMISMED.BO 300705.SZ JENBURPH.BO KPL.BO
Market cap 7.07B 47.96B 8.32B 5.27B 3.80B 36.65B
P/E (TTM) 23.0 28.6 20.9 13.7 11.6 45.2
Forward P/E 13.2 15.7 — 7.5 24.7 —
Price/book 2.5 2.7 2.1 2.0 1.9 11.1
Dividend yield — 0.58% 0.53% 3.88% 2.36% —
1-year change +9.40% +84.61% −25.44% −39.19% −18.06% +295.79%
Today +0.06% −4.72% −3.99% +2.03% −1.93% −2.48%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Univest·Negative

Kilitch Drugs (India) Share Price Falls 8.18% | Analysis

Kilitch Drugs (India) (KILITCH) fundamental metrics show P/E 25.67x, P/B 2.74x, ROE 12.26%, ROCE 14.5%. These figures provide context only and are not a buy or sell signal. Kilitch Drugs (India) (KILITCH) operates in the Healthcare sector,…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.